Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_provenance.
- NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_assertion description "[We have investigated whether the -86 C/T promoter polymorphism in CHRNA7 gene, the signal peptide polymorphism of the alpha1-antichymotripsin (ACT) gene or the APOE genotype are associated with an increased risk of mild cognitive impairment (MCI) or affect the risk of evolution to Alzheimer's disease (AD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_provenance.
- NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_assertion evidence source_evidence_literature NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_provenance.
- NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_assertion SIO_000772 18078695 NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_provenance.
- NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_assertion wasDerivedFrom befree-2016 NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_provenance.
- NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_assertion wasGeneratedBy ECO_0000203 NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_provenance.
- befree-2016 importedOn "2016-02-19" NP645098.RAgQGiwznJQ2guEicatOhYvaOrzTclZtrHj3zoR48fB5M130_provenance.